Πίσω
Πίσω

20-04-2022

01 Ι.Βαμβακάρης - Χαιρετισμός

01 Ι.Βαμβακάρης - Χαιρετισμός

02 Β. Σκούρας - Evolving approach of Lung Cancer in the years of COVID-19. Should we change our philosophy about screening, TNM and elderlies?

02 Β. Σκούρας - Evolving approach of Lung Cancer in the year...

03 Δ. Μπούκλας - The emerging role of pathology in the treatment of Lung Cancer: not enough anymore microscopic diagnosis only

03 Δ. Μπούκλας - The emerging role of pathology in the treat...

04 Σ. Γαϊτανάκης - The new prospectives of thoracic surgery: more targeted, more accurate, more collaborative

04 Σ. Γαϊτανάκης - The new prospectives of thoracic surgery:...

05 Ε. Μπερούκας - Radiotherapy: a “passe-partout” against NSCLC. Old and new therapeutic keys

05 Ε. Μπερούκας - Radiotherapy: a “passe-partout” against NS...

06 Ε.Γ. Φεργάδης - Oncologic approach of Lung Cancer in the era of personalized medicine: an equation with many parameters and factors

06 Ε.Γ. Φεργάδης - Oncologic approach of Lung Cancer in the...

07 Σ. Γαϊτανάκης και Ε. Μπερούκας - Hot spot questions to be answered Surgery vs radiation

07 Σ. Γαϊτανάκης και Ε. Μπερούκας - Hot spot questions to be...

08 Β. Σκούρας Ε.Γ. Φεργάδης - Duration of IO: limited vs forever

08 Β. Σκούρας Ε.Γ. Φεργάδης - Duration of IO: limited vs for...

09 Δ. Μπούκλας - AI and telemedicine: help vs substitute the medical doctor

09 Δ. Μπούκλας - AI and telemedicine: help vs substitute the...

10 Π. Μπακάκος - Αποχαιρετισμός

10 Π. Μπακάκος - Αποχαιρετισμός